EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Thiazolylimidazole Hybrids as Promising Antileishmanial Agents: Rational Design and Biological Evaluation

Cristoper Ramírez-Sandoval iD, María Elena Campos-Aldrete iD, María Estela Meléndez-Camargo

Pathogens · 2026

DOI: 10.3390/pathogens15050544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Cristoper Ramírez-Sandoval und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación 7 y 10, Departamento de Química Orgánica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolo…. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Imidazoles, Thiazoles, Leishmania mexicana. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Politécnico Nacional, Secretaría de Investigación y Posgrado, Consejo Nacional de Humanidades, Ciencias y Tecnologías.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis remains a major neglected tropical disease with limited therapeutic options, challenged by drug toxicity and emerging resistance to current treatments like miltefosine. In this study, a virtual library of approximately 150 azole-derived compounds was screened in silico to identify promising thiazole and imidazole scaffolds, leading to the rational design of novel hybrid molecules. Molecular docking against thioredoxin reductase (PDB ID: 4CBQ), a key enzyme in the redox metabolism of Leishmania mexicana, showed improved binding affinity compared to miltefosine, with compound 3f showing the most favourable interaction profile. Among the synthesized series 3a–f, compound 3f (4-NO2Ph) exhibited the most favourable predicted binding parameters within the series (∆G = −16.08, Ki = 0.0019 nM). Biological evaluation was performed against L. mexicana promastigotes as an early-stage phenotypic screening model to identify active compounds with potential relevance during the initial infective phase, and a markedly improved in vitro inhibitory effect (IC50 = 22.41 µM) compared to miltefosine (IC50 = 132.42 µM), representing a six-fold increase in molar potency. Furthermore, hybrid thiazolyl–imidazole systems (series 3) consistently outperformed single-core analogues, likely due to enhanced molecular planarity and lipophilicity provided by the imine linkage. Cytotoxicity assays in Vero cells revealed a high safety margin for the lead compounds, with compound 3f achieving a Selectivity Index (SI) of around 89, significantly outperforming the reference drug. Acute toxicity studies (LD50) in murine models further confirmed the safety profile, with values exceeding 2000 mg/kg for the most active derivatives. These findings identify thiazolyl–imidazole hybrids as promising early-stage scaffolds for antileishmanial drug discovery, particularly for early infection/prophylactic screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsImidazolesThiazolesLeishmania mexicanaAnimalsMolecular Docking SimulationDrug DesignMiceThioredoxin-Disulfide ReductaseLeishmaniasis

Stichwörter der Autor:innen

Leishmania mexicanaleishmania promastigotesmiltefosine resistancethiazolyl–imidazole hybridsthioredoxin reductase

Substanzen

Antiprotozoal AgentsImidazolesThiazolesimidazoleThioredoxin-Disulfide Reductase

Autor:innen und Institutionen

  • Laboratorio de Investigación 7 y 10, Departamento de Química Orgánica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Colonia Santo Tomás, Mexico Cit…
  • Laboratorio de Toxicología de Productos Naturales, Departamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Campus Zacatenco, Instituto Politécnico Nacional, Av. Wilfrido Massieu s/n Col. Zacatenco, Mexico Cit…

ORCID-Profile: Cristoper Ramírez-Sandoval, María Elena Campos-Aldrete

Förderung

  • Instituto Politécnico Nacional
  • Secretaría de Investigación y Posgrado
  • Consejo Nacional de Humanidades, Ciencias y Tecnologías

Zitieren

APA

Ramírez-Sandoval, C., Campos-Aldrete, M. E., & Meléndez-Camargo, M. E. (2026). Novel Thiazolylimidazole Hybrids as Promising Antileishmanial Agents: Rational Design and Biological Evaluation. Pathogens. https://doi.org/10.3390/pathogens15050544

Vancouver

Ramírez-Sandoval C, Campos-Aldrete ME, Meléndez-Camargo ME. Novel Thiazolylimidazole Hybrids as Promising Antileishmanial Agents: Rational Design and Biological Evaluation. Pathogens. 2026. doi:10.3390/pathogens15050544

BibTeX
@article{RamrezSandoval2026,
  author = {Ramírez-Sandoval, Cristoper and Campos-Aldrete, María Elena and Meléndez-Camargo, María Estela},
  title = {Novel Thiazolylimidazole Hybrids as Promising Antileishmanial Agents: Rational Design and Biological Evaluation},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15050544}
}
Kostenlos starten →